Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
奈非那韦联合来那度胺/地塞米松治疗来那度胺难治性多发性骨髓瘤患者。一项 I/II 期临床试验 (SAKK 39/10)
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-019-0228-2
Hitz, F; Kraus, M; Pabst, T; Hess, D; Besse, L; Silzle, T; Novak, U; Seipel, K; Rondeau, S; Stüdeli, S; Vilei, S Berardi; Samaras, P; Mey, U; Driessen, C